Yongfei Tan Selected Research

Yongfei Tan Research Topics

Disease

24	Neoplasms (Cancer) 01/2019 - 12/2006
19	Stomach Neoplasms (Stomach Cancer) 01/2018 - 12/2006
7	Neoplasm Metastasis (Metastasis) 12/2017 - 01/2012
5	Carcinogenesis 01/2018 - 04/2007
4	Esophageal Neoplasms (Esophageal Cancer) 06/2015 - 01/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 03/2015
2	Carcinoma (Carcinomatosis) 11/2014 - 05/2012
2	Esophageal Squamous Cell Carcinoma 06/2014 - 03/2008
2	Lymphatic Metastasis 01/2013 - 01/2012
1	Adenocarcinoma 01/2018
1	Pleural Effusion (Pleural Effusions) 12/2017
1	Meningioma (Meningiomas) 12/2017
1	Colorectal Neoplasms (Colorectal Cancer) 07/2017
1	Insulin Resistance 03/2017
1	Anemia 03/2017
1	Neonatal Sepsis 03/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Lymphoma (Lymphomas) 03/2015
1	Lung Neoplasms (Lung Cancer) 03/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2013

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2012
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
4	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 05/2013
3	ParaffinIBA 01/2018 - 11/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2012
3	PlatinumIBA 01/2015 - 01/2012
2	EnzymesIBA 01/2018 - 12/2017
2	Mitogen-Activated Protein KinasesIBA 03/2015 - 06/2014
2	MicroRNAs (MicroRNA)IBA 01/2014 - 11/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2013 - 05/2013
2	Leucovorin (Folinic Acid)FDA Link 09/2013 - 05/2013
2	X-ray Repair Cross Complementing Protein 1IBA 03/2013 - 05/2012
2	Transforming Growth Factor-beta Type II ReceptorIBA 03/2008 - 03/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2008 - 03/2007
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2007 - 12/2006
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 06/2018
1	NucleotidesIBA 01/2018
1	ImmunosorbentsIBA 12/2017
1	C-Reactive ProteinIBA 03/2017
1	Blood Glucose (Blood Sugar)IBA 03/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2017
1	BerberineIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 09/2015
1	Small Interfering RNA (siRNA)IBA 03/2015
1	CopperIBA 03/2015
1	Protein Kinases (Protein Kinase)IBA 03/2015
1	DiosgeninIBA 01/2015
1	SB 203580IBA 01/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2014
1	Orphan Nuclear ReceptorsIBA 12/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Carrier Proteins (Binding Protein)IBA 02/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2014
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2013
1	Proto-Oncogene Proteins c-mdm2IBA 05/2013
1	Codon (Codons)IBA 03/2013
1	Indicators and Reagents (Reagents)IBA 03/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2012
1	Complement System Proteins (Complement)IBA 05/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	AntigensIBA 09/2011
1	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 07/2011
1	lissamine rhodamine B (sulforhodamine B)IBA 03/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2008
1	Insulin-Like PeptidesIBA 04/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2008
1	LigandsIBA 06/2007
1	ErbB Receptors (EGF Receptor)IBA 06/2007
1	Epidermal Growth Factor (EGF)IBA 06/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2007
1	HomocysteineIBA 04/2007
1	Reduced Folate Carrier ProteinIBA 12/2006

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
5	Therapeutics 01/2018 - 09/2011
2	Gastrectomy 01/2018 - 07/2014
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017
1	Prostatectomy (Retropubic Prostatectomy) 06/2015
1	Adjuvant Chemotherapy 01/2015